MetaVia is trading up 5.43% in pre-market at $1.36, versus the previous close of $1.29; no company-specific announcement explaining the move was found in available search results.
- The latest located company announcement was the October 13 appointment of Sarah Browne as Chief Medical Officer; it is not evidence of a catalyst for this October 21 move.
- Major indexes are up less than 0.5%, so broader-market context does not clearly explain the increase.